Results 1 to 10 of about 58,626 (275)
Monoclonal antibodies against human CD34 antigens do not cross-react with ovine umbilical cord blood cells [PDF]
Italian Journal of Animal Science, 2010 CD34 is a cell surface glycoprotein expressed by hematopoietic progenitors and endothelial cells. It is widely used in the clinic for isolation of human hematopoietic stem cells.
Maria Dattena +4 more
doaj +5 more sources
Frontiers in Veterinary Science, 2022 Haematopoietic stem and progenitor cells (HSPCs) are used for transplantation to reconstruct the haematopoietic pathways in humans receiving severe chemotherapy.
Taro Ayabe +9 more
doaj +1 more source
CD117 expression on blast cells in acute myeloid leukemia. [PDF]
Medičnì Perspektivi, 2015 The aim of the present work was to analyze the frequency of CD117 (c-KIT) antigen expression on the blast cells in acute myeloid leukemia (AML), evaluation of the presence of the relationship between the expression of the c-KIT and leukemia according to ...
N. V. Goryainova +2 more
doaj +2 more sources
Beneficial effects of reconstituted high-density lipoprotein (rHDL) on circulating CD34+ cells in patients after an acute coronary syndrome [PDF]
, 2017 Background: High-density lipoproteins (HDL) favorably affect endothelial progenitor cells (EPC). Circulating progenitor cell level and function are impaired in patients with acute coronary syndrome (ACS).
Alam, Mohammad Afaque +15 more
core +17 more sources
A review of TSHR- and IGF-1R-related pathogenesis and treatment of Graves’ orbitopathy
Frontiers in Immunology, 2023 Graves’ orbitopathy (GO) is an organ-specific autoimmune disease, but its pathogenesis remains unclear. There are few review articles on GO research from the perspective of target cells and target antigens.
Xuejiao Cui, Futao Wang, Cong Liu
doaj +1 more source
Frontiers in Pediatrics, 2023 BackgroundCD34+CD38− lymphoblasts as likely leukemia stem cells (LSCs) may be responsible for a worse response to treatment and may be a risk factor for recurrence in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).ObjectiveThe study objective ...
Weronika Stolpa +4 more
doaj +1 more source
Alginate-Chitosan Microencapsulated Cells for Improving CD34+ Progenitor Maintenance and Expansion
Applied Sciences, 2021 Protocols for isolation, characterization, and transplantation of hematopoietic stem cells (HSCs) have been well established. However, difficulty in finding human leucocyte antigens (HLA)-matched donors and scarcity of HSCs are still the major obstacles ...
Retno Wahyu Nurhayati +6 more
doaj +1 more source
CD34 antigen: Molecular features and potential clinical applications [PDF]
Stem Cells, 1993 Despite the wide variety of functions exhibited by mature peripheral blood cells, all are derived from a small pool (1-3%) of primitive precursor cells in the bone marrow (BM) that bear a unique surface glycoprotein, CD34. Isolated CD34+ cells are capable of reconstituting all hematopoietic lineages, both in experimental animals and in humans following
D R, Sutherland +2 more
openaire +2 more sources
Hematology, Transfusion and Cell Therapy, 2023 Background: T lymphocytes expressing chimeric antigen receptors (CAR) have been shown to be efficient for tretment of hematologic, but less efficient for solid tumors, due to the great complexity of the tumor microenvironment involving: heterogeneity of ...
IC Ovider +7 more
doaj +1 more source
Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase [PDF]
, 2020 Minor histocompatibility antigens are the main targets of donor-derived T-cells after allogeneic stem cell transplantation. Identification of these antigens and understanding their biology are a key requisite for more insight into how graft vs.
Bausenwein, Judith +13 more
core +2 more sources